Stem cell therapy in neurodegenerative diseases: From principles to practice.

Rajalingham Sakthiswary, Azman Ali Raymond
Author Information
  1. Rajalingham Sakthiswary: Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia.
  2. Azman Ali Raymond: Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia.

Abstract

The lack of curative therapies for neurodegenerative diseases has high economic impact and places huge burden on the society. The contribution of stem cells to cure neurodegenerative diseases has been unraveled and explored extensively over the past few years. Beyond substitution of the lost neurons, stem cells act as immunomodulators and neuroprotectors. A large number of preclinical and a small number of clinical studies have shown beneficial outcomes in this context. In this review, we have summarized the current concepts of stem cell therapy in neurodegenerative diseases and the recent advances in this field, particularly between 2010 and 2012. Further studies should be encouraged to resolve the clinical issues and vague translational findings for maximum optimization of the efficacy of stem cell therapy in neurodegenerative diseases.

Keywords

References

  1. PLoS One. 2011;6(5):e19926 [PMID: 21655272]
  2. PM R. 2011 Jun;3(6 Suppl 1):S117-22 [PMID: 21703567]
  3. Neurol India. 2011 Jul-Aug;59(4):555-7 [PMID: 21891933]
  4. CNS Neurol Disord Drug Targets. 2011 Jun;10(4):459-85 [PMID: 21495961]
  5. Genes Dev. 1996 Dec 15;10(24):3129-40 [PMID: 8985182]
  6. Mol Cell Neurosci. 1998 Jul;11(4):234-45 [PMID: 9675054]
  7. N Engl J Med. 2001 Jul 12;345(2):146; author reply 147 [PMID: 11450669]
  8. J Neurosci. 2007 Jan 10;27(2):412-21 [PMID: 17215402]
  9. Cytotherapy. 2012 Jan;14 (1):56-60 [PMID: 21954839]
  10. Cell. 2008 Feb 22;132(4):645-60 [PMID: 18295581]
  11. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13632-7 [PMID: 14581618]
  12. Mol Cell Neurosci. 1992 Feb;3(1):44-8 [PMID: 19912844]
  13. Trends Pharmacol Sci. 2009 May;30(5):260-7 [PMID: 19362379]
  14. Nat Med. 2009 Mar;15(3):331-7 [PMID: 19198615]
  15. J Neurochem. 2005 Feb;92(4):718-29 [PMID: 15686473]
  16. J Cell Biochem. 2008 Dec 1;105(5):1153-60 [PMID: 18980212]
  17. PLoS One. 2011;6(6):e20692 [PMID: 21673956]
  18. Lancet Neurol. 2011 Apr;10(4):383-94 [PMID: 21435601]
  19. Mol Ther. 2009 Oct;17(10):1761-70 [PMID: 19603007]
  20. Mol Neurobiol. 2012 Feb;45(1):87-98 [PMID: 22161544]
  21. Glia. 2005 Feb;49(3):385-96 [PMID: 15538751]
  22. J Neurochem. 2009 Oct;111(1):204-16 [PMID: 19659571]
  23. Nat Neurosci. 2008 Nov;11(11):1294-301 [PMID: 18931666]
  24. Ann Neurol. 2003 Sep;54(3):403-14 [PMID: 12953276]
  25. Neurobiol Aging. 2011 Jan;32(1):140-50 [PMID: 19201065]
  26. PLoS Med. 2009 Feb 17;6(2):e1000029 [PMID: 19226183]
  27. Curr Alzheimer Res. 2006 Sep;3(4):393-6 [PMID: 17017869]
  28. Exp Neurol. 2010 Jul;224(1):155-62 [PMID: 20227407]
  29. Curr Alzheimer Res. 2006 Sep;3(4):339-49 [PMID: 17017864]
  30. Neurol Res. 2012 Mar;34(2):129-42 [PMID: 22333068]
  31. Curr Opin Mol Ther. 2009 Aug;11(4):394-403 [PMID: 19649984]
  32. Nat Neurosci. 1999 Dec;2(12):1137-40 [PMID: 10570493]
  33. Stem Cells. 2010 Mar 31;28(3):501-12 [PMID: 20049900]
  34. J Intern Med. 2009 Oct;266(4):358-71 [PMID: 19765180]
  35. Lancet. 2007 Jun 16;369(9578):2031-41 [PMID: 17574095]
  36. BMC Cell Biol. 2011 Sep 12;12:39 [PMID: 21910887]
  37. PLoS One. 2010 Feb 22;5(2):e9347 [PMID: 20179764]
  38. Exp Neurol. 2004 Nov;190(1):42-58 [PMID: 15473979]
  39. J Urol. 2012 Apr;187(4):1491-7 [PMID: 22341818]
  40. Nature. 2008 Jul 31;454(7204):646-50 [PMID: 18594515]
  41. Biomaterials. 2010 Mar;31(8):2105-20 [PMID: 20005569]
  42. Curr Alzheimer Res. 2012 Mar;9(3):278-89 [PMID: 22272614]
  43. Cell Transplant. 2012;21(9):1899-907 [PMID: 23356668]
  44. Behav Brain Res. 2010 Dec 25;214(2):193-200 [PMID: 20493905]
  45. Eur J Neurosci. 2003 Aug;18(4):923-30 [PMID: 12925018]
  46. Behav Brain Res. 2012 Feb 14;227(2):433-9 [PMID: 22019362]
  47. Neurosci Lett. 2012 Jun 25;519(2):87-92 [PMID: 22306614]
  48. Nature. 2010 Feb 25;463(7284):1035-41 [PMID: 20107439]
  49. J Neurochem. 2006 Nov;99(3):913-23 [PMID: 17076658]
  50. Nature. 2002 Jul 4;418(6893):50-6 [PMID: 12077607]
  51. Neuron. 2002 Aug 1;35(3):419-32 [PMID: 12165466]
  52. J Neurosci. 2002 Jan 15;22(2):437-45 [PMID: 11784788]
  53. Mol Ther. 2008 Dec;16(12 ):2002-10 [PMID: 18797452]
  54. Cell Transplant. 2011;20(3):371-9 [PMID: 20875225]
  55. Ageing Res Rev. 2010 Nov;9 Suppl 1:S36-46 [PMID: 20732460]
  56. Cell. 2009 Feb 6;136(3):411-9 [PMID: 19203577]
  57. Biochim Biophys Acta. 2011 Jan;1812(1):1-11 [PMID: 20713152]
  58. J Clin Invest. 2005 Jan;115(1):102-9 [PMID: 15630449]
  59. J Neuropathol Exp Neurol. 2011 Sep;70(9):736-47 [PMID: 21865882]
  60. PLoS One. 2007 Aug 01;2(8):e689 [PMID: 17668067]
  61. Cell Stem Cell. 2009 Sep 4;5(3):310-9 [PMID: 19733542]
  62. Neuropharmacology. 2010 May;58(6):845-54 [PMID: 20036262]
  63. J Neurochem. 2009 Apr;109(1):238-47 [PMID: 19187439]
  64. J Neurosci Res. 2009 Aug 1;87(10):2183-200 [PMID: 19301431]
  65. Mol Cell Neurosci. 2002 Nov;21(3):512-20 [PMID: 12498791]
  66. Langenbecks Arch Surg. 2011 Apr;396(4):489-97 [PMID: 21373941]
  67. J Cereb Blood Flow Metab. 2008 Sep;28(9):1552-63 [PMID: 18478023]
  68. PLoS One. 2011;6(8):e22924 [PMID: 21850243]
  69. J Neurosci. 2000 Dec 15;20(24):9104-10 [PMID: 11124987]
  70. J Neurosci. 2005 May 11;25(19):4694-705 [PMID: 15888645]
  71. Neurologia. 2010 Oct;25(8):467-9 [PMID: 20964996]
  72. Stem Cells. 2009 Aug;27(8):2009-21 [PMID: 19544469]
  73. Brain Res. 2011 Aug 11;1406:84-105 [PMID: 21742312]
  74. Transl Res. 2010 Sep;156(3):155-60 [PMID: 20801412]
  75. Cell Stem Cell. 2009 Jun 5;4(6):472-6 [PMID: 19481515]
  76. Eur J Pharmacol. 2001 Jan 5;411(1-2):67-70 [PMID: 11137860]
  77. Curr Drug Targets. 2012 Apr;13(4):561-71 [PMID: 22443584]
  78. CNS Neurosci Ther. 2012 Jan;18(1):4-13 [PMID: 22280157]
  79. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13594-9 [PMID: 19633196]
  80. Nat Rev Neurosci. 2007 Jun;8(6):481-8 [PMID: 17514200]
  81. Nat Biotechnol. 2008 Dec;26(12):1364-6 [PMID: 19029913]
  82. Mov Disord. 2011 Sep;26(11):1997-2003 [PMID: 21611977]
  83. J Comp Neurol. 2001 Jul 9;435(4):406-17 [PMID: 11406822]
  84. N Engl J Med. 2001 Mar 8;344(10):710-9 [PMID: 11236774]
  85. Curr Opin Genet Dev. 2011 Jun;21(3):354-61 [PMID: 21277194]
  86. Exp Neurol. 2007 Feb;203(2):394-405 [PMID: 17034791]
  87. Development. 1999 Sep;126(18):4017-26 [PMID: 10457011]
  88. Nat Biotechnol. 1999 Jul;17(7):653-9 [PMID: 10404157]
  89. J Comp Neurol. 2004 Jul 19;475(2):211-9 [PMID: 15211462]
  90. Behav Brain Res. 2012 Feb 14;227(2):410-7 [PMID: 21871501]
  91. Cell Stem Cell. 2010 May 7;6(5):445-56 [PMID: 20452319]
  92. Cell Mol Life Sci. 2011 Feb;68(4):635-49 [PMID: 20976521]
  93. Curr Opin Neurol. 2007 Dec;20(6):688-92 [PMID: 17992090]
  94. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3168-71 [PMID: 9501234]
  95. Prog Brain Res. 2002;138:3-14 [PMID: 12432759]
  96. Neurotox Res. 2009 May;15(4):367-80 [PMID: 19384570]

Word Cloud

Created with Highcharts 10.0.0stemcellsneurodegenerativediseasescelltherapydiseasenumberclinicalstudieslackcurativetherapieshigheconomicimpactplaceshugeburdensocietycontributioncureunraveledexploredextensivelypastyearsBeyondsubstitutionlostneuronsactimmunomodulatorsneuroprotectorslargepreclinicalsmallshownbeneficialoutcomescontextreviewsummarizedcurrentconceptsrecentadvancesfieldparticularly20102012encouragedresolveissuesvaguetranslationalfindingsmaximumoptimizationefficacyStemdiseases:principlespracticeAlzheimer'sHuntington'sParkinson'samyotrophiclateralsclerosisembryonicinducedpluripotentmesenchymalneural

Similar Articles

Cited By (35)